Skip to content

Identification of Entamoeba Spp. in Assuit Governorate Hospitals.

Different Methods for Detection and Identification of Entamoeba Species in Assuit Governorate Hospitals.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04466449
Enrollment
138
Registered
2020-07-10
Start date
2022-09-30
Completion date
2022-10-31
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Entamoeba Spp. Identification

Brief summary

1. Determination the prevalence of Entamoeba histolytica infections among patients at Assiut University Hospitals presented with diarrhea/dysentery. 2. Evaluatation the role of different cultures in diagnosing Entamoeba . 3. Molecularly differentiation between Entamoeba species to monitor the true prevalence of E.histolytica .

Detailed description

Entamoeba histolytica is a common pathogenic protozoan widely distributed throughout the world (10% of the world's population), with 50,000-100,000 deaths reported annually(1) .It is a health problem both in Egypt and worldwide (2) The disease is more prevalent in densely populated areas with poor hygiene requirements and lacking sanitary water supply, especially in rural areas(3). It causes many digestive complications including diarrhea , and fever(2). it transmits through bloodstream forming abscesses in the brain, eye, liver and other vital organs and tissues or even lead to death in some cases . Some individuals have no symptom of the disease but transmit the infection to others(4) It is well- established that E. histolytica leads to invasive disease in humans. Although both E. dispar and E. moshkovskii are still considered to be non pathogenic and free-living amoebas, respectively, some reports suggest their potential role in provoking disease in humans (5) Cysts of E.dispar , E.moshkovskii and E.hartmanni can be confused with E.histolytica. cysts in the parasitological examination(6) The molecular assays, is preferable as it detects E. histolytica , differentiates it from other species and monitors its true prevalence for better treatment and effective control (2)

Interventions

DIAGNOSTIC_TESTstool sample

A stool sample will be collected from each patient for diagnosis of Entamoeba

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL

Inclusion criteria

* : Male and female patients of different age groups with diarrhea/dysentery attending the outpatient clinics at Assiut University Hospitals .

Exclusion criteria

* No

Design outcomes

Primary

MeasureTime frameDescription
Determination the prevalence of Entamoeba histolytica infections among patients at Assiut University Hospitals presented with diarrhea/dysentery2022Different Methods for Detection and Identification of Entamoeba species in Assuit Governorate.

Countries

Egypt

Contacts

Primary ContactYoustina Talaat
youstinatalaat63@gmail.com01225530091
Backup ContactAbeer Lsayed Mahmoud
abeerwns@yahoo.com01028241777

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026